A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Emedastine
Ertugliflozin
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Ertugliflozin.
Emedastine
Canagliflozin
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Canagliflozin.
Emedastine
Linagliptin
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Linagliptin.
Emedastine
Dapagliflozin
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Dapagliflozin.
Emedastine
Balaglitazone
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Balaglitazone.
Emedastine
Ciglitazone
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Ciglitazone.
Emedastine
Rivoglitazone
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Rivoglitazone.
Emedastine
Netoglitazone
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Netoglitazone.
Emedastine
Lobeglitazone
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Lobeglitazone.
Emedastine
Alogliptin
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Alogliptin.
Emedastine
Saxagliptin
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Saxagliptin.
Emedastine
Liraglutide
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Liraglutide.
Emedastine
Insulin glulisine
The risk or severity of hypoglycemia can be increased when Insulin glulisine is combined with Zimelidine.
Emedastine
Insulin detemir
The risk or severity of hypoglycemia can be increased when Insulin detemir is combined with Zimelidine.
Emedastine
Insulin aspart
The risk or severity of hypoglycemia can be increased when Insulin aspart is combined with Zimelidine.
Emedastine
Pramlintide
The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Zimelidine.
Emedastine
Mecasermin
The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Zimelidine.
Emedastine
Exenatide
The risk or severity of hypoglycemia can be increased when Exenatide is combined with Zimelidine.
Emedastine
Gliclazide
The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Zimelidine.
Emedastine
Gastric inhibitory polypeptide
The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Gastric inhibitory polypeptide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3